Food, Inc. Documentary Screening to be Held at UC College of Medicine
In Food, Inc., producer-director Robert Kenner and investigative authors Eric Schlosser (Fast Food Nation) and Michael Pollan (The Omnivores Dilemma) lift the veil on the
The
Barb Kowalcyk, an epidemiology and biostatistics doctoral student in UCs environmental health department, is featured in the film. Kowalcyk lost her son in 2001 to an E. coli O157:H7 infection when he was just 2½ years old. Since then, she has been on a mission to educate others about the genesis and dangers of foodborne illnesses.
We put faith in our government to protect us, and were not being protected at the most basic level, says Kowalcyk, who advocates for food safety through her nonprofit organization, the Center for Foodborne Illness Research & Prevention. Continuing down the current path that produced the huge assortment of recalls over the past two years defies good science and common sense.
Ultimately, if our nation is to make meaningful progress in reducing death and disease from foodborne illness in the 21st century, we must recognize foodborne illness as a serious public health issue and work to build an environment that promotes food safety and consumer health throughout the farm to fork continuum, she adds.
According to the Centers for Disease Control, an estimated 76 million Americans are sickened, 325,000 are hospitalized and 5,000 die each year from preventable foodborne disease.E. coli alone causes illness for an estimated 73,000 Americans annually.
For more information on the screening event, visit healthnews.uc.edu. For more information on the film, visit foodincmovie.com.
Food, Inc. filmmakers say the food industry has often put profit ahead of consumer health, the livelihood of American farmers, the safety of workers and the environment.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.